Amgen - Belgium
Telecomlaan 5-7
1831 Machelen (Brab.)
BE
Amgen - Belgium
Foundation date
21/12/1989
Sector
#PharmaSubsector
Amgen, a biotechnology pioneer, discovers, develops, and delivers innovative human therapeutics. Our medicines help millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, we continue to advance science to serve patients.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Latest news
More news-
Bimekizumab Phase 3 data in hidradenitis suppurativa show clinically meaningful, deep and maintained response over 48 weeks
Monday March 20th 2023
Read more
-
VIB launches Data Core to support life sciences research
Thursday March 16th 2023
Read more
-
Aitia and UCB announce strategic drug discovery collaboration in Huntington's Disease
Thursday March 16th 2023
Read more
Jobs
More jobs-
21/03/23
Flemish Brabant
PhD position - Improved cytogenomic diagnosis in lymphoma: opportunities of optical genome mapping and long-read sequencing.
Temporary
KU Leuven -
21/03/23
Antwerp
Valorisation Manager for the IOF consortium IMARK, IOF platform for image-based biomarkers
Permanent
University of Antwerp -